---
title: "New study finds Ozempic and Mounjaro protect the heart too"
date: 2025-11-12T16:03:00.000Z
category: Health
externalLink: "https://www.sciencedaily.com/releases/2025/11/251112011814.htm"
image: ""
excerpt: "New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, semaglutide (Ozempic) and tirzepatide (Mounjaro), not only promote weight loss but also significantly reduce the risk of heart attacks and strokes in patients with type 2 diabetes. Using real-world insurance data, the study found up to an 18% reduction in major cardiovascular events,â€¦"
---